clinical trial · NCT07057323
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure
Heart Failure Preserved Ejection FractionCoronary Sinus Reducer
brief summary
The purpose of this study is to evaluate the efficacy of CS Reducer implantation in patients with HFpEF and CMD on left ventricular filling pressures, specifically invasive measurement of PAWP during standardized exercise.
started
Oct 16, 2025
primary completion
Aug 1, 2027
completion
Aug 1, 2027
last updated
Mar 20, 2026
official title
Coronary Sinus Reducer For The Management Of Symptomatic Heart Failure With A Preserved Ejection Fraction Associated With Coronary Microvascular Dysfunction
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol